Frequency and Severity of Cognitive Impairment Across Stages of Chronic Kidney Disease: A Cross-Sectional Study from A Tertiary Nephrology Centre in Rajasthan, India

Prashant Patil; Pratik Tripathi; Kishalay Mahajan

doi:10.55489/njmr.160420261316

Authors

Prashant Patil Department of Nephrology, NIMS University, Jaipur, Rajasthan, India
Pratik Tripathi Department of Nephrology, NIMS University, Jaipur, Rajasthan, India
Kishalay Mahajan Department of Nephrology, NIMS University, Jaipur, Rajasthan, India

DOI:

https://doi.org/10.55489/njmr.160420261316

Keywords:

Chronic Kidney Disease, Cognitive Impairment, Mini-Mental State Examination, Montreal Cognitive Assessment, Hemodialysis

Abstract

Background: Chronic kidney disease (CKD) is increasingly recognized as a risk factor for cognitive impairment, which may affect treatment adherence, daily functioning, and quality of life. Cognitive dysfunction may begin in earlier CKD stages and worsen with disease progression, but data across the full CKD stage spectrum remain limited.

Objective: To evaluate the prevalence and severity of cognitive impairment across CKD stages and to identify clinical factors associated with lower Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) scores.

Methods: This cross-sectional study included 138 adults with CKD stages 2-5, including patients on maintenance hemodialysis (HD), recruited from a tertiary nephrology center in Rajasthan over 18 months. All participants underwent clinical and laboratory evaluation, estimated glomerular filtrations rate (eGFR) estimation by the Modification of Diet in Renal Disease (MDRD) equation, and cognitive assessment using the MMSE and MoCA. Associations were examined using correlation analysis and univariate and multivariable linear regression.

Results: Mean MMSE and MoCA scores declined progressively with worsening CKD stage and were lowest in dialysis-dependent stage 5 disease. Cognitive impairment was identified in 67.4% of patients by MMSE and 49.3% by MoCA. In unadjusted analyses, older age, higher systolic blood pressure, lower hemoglobin, lower eGFR, and higher blood urea, serum creatinine, phosphate, and potassium levels were associated with worse cognitive scores. In adjusted analyses, blood urea remained independently associated with lower MMSE and MoCA scores, while eGFR remained an adjusted correlate of cognitive performance.

Conclusion: Cognitive impairment increases with CKD severity and is most pronounced in dialysis-dependent patients. Routine cognitive screening using brief tools such as MMSE and MoCA may help identify at-risk CKD patients.

References

1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024 Apr;105(4S):S117-S314. DOI: https://doi.org/10.1016/j.kint.2023.10.018 PMid:38490803

2. Drew DA, Weiner DE, Sarnak MJ. Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention. Am J Kidney Dis. 2019 Dec;74(6):782-790. DOI: https://doi.org/10.1053/j.ajkd.2019.05.017 PMid:31378643 PMCID: PMC7038648

3. Bolignano D, Simeoni M, Hafez G, Pepin M, Gallo A, Altieri M, et al. Cognitive impairment in CKD patients: a guidance document by the CONNECT network. Clin Kidney J. 2024 Sep 30;18(2):sfae294. DOI: https://doi.org/10.1093/ckj/sfae294 PMid:40235626 PMCid:PMC11997768

4. Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, et al. Cognitive impairment in hemodialysis patients is common. Neurology. 2006 Jul 25;67(2):216-223. DOI: https://doi.org/10.1212/01.wnl.0000225182.15532.40. Erratum in: Neurology. 2007 Jul 3;69(1):120. PMID: 16864811

5. Viggiano D, Wagner CA, Martino G, Nedergaard M, Zoccali C, Unwin R, et al. Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol. 2020 Aug;16(8):452-469. DOI: https://doi.org/10.1038/s41581-020-0266-9 PMid:32235904

6. Weiner DE, Seliger SL. Cognitive and physical function in chronic kidney disease. Curr Opin Nephrol Hypertens. 2014;23(3):291-297. DOI: https://doi.org/10.1097/01.mnh.0000444821.87873.7b PMid:24638060 PMCid:PMC4052721

7. Lee SH, Cho A, Min YK, Lee YK, Jung S. Comparison of the montreal cognitive assessment and the mini-mental state examination as screening tests in hemodialysis patients without symptoms. Ren Fail. 2018 Nov;40(1):323-330. DOI: https://doi.org/10.1080/0886022X.2018.1455589 PMid:29633885 PMCid:PMC6014510

8. Etgen T, Chonchol M, Förstl H, Sander D. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol. 2012;35(5):474-482. DOI: https://doi.org/10.1159/000338135 PMid:22555151

9. Al Lawati H, Al Zadjali F, Al Salmi I, Al Kindi M. Performance of Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration Equations Versus 99Tc-DTPA-Renogram in Assessing Kidney Function. Oman Med J. 2024;39(2):e606. DOI: https://doi.org/10.5001/omj.2024.54 PMid:38988799 PMCid:PMC11234170

10. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198. DOI: https://doi.org/10.1016/0022-3956(75)90026-6 PMid:1202204

11. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-699. DOI: https://doi.org/10.1111/j.1532-5415.2005.53221.x. Erratum in: J Am Geriatr Soc. 2019 Sep;67(9):1991. DOI: https://doi.org/10.1111/jgs.15925. PMID: 15817019

12. Murtaza A, Dasgupta I. Chronic Kidney Disease and Cognitive Impairment. J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105529. DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105529 PMid:33323323

13. Bronas UG, Puzantian H, Hannan M. Cognitive Impairment in Chronic Kidney Disease: Vascular Milieu and the Potential Therapeutic Role of Exercise. Biomed Res Int. 2017;2017:2726369. DOI: https://doi.org/10.1155/2017/2726369 PMid:28503567 PMCid:PMC5414492

14. Aggarwal HK, Jain D, Bhavikatti A. Cognitive Dysfunction in Patients with Chronic Kidney Disease. Saudi J Kidney Dis Transpl. 2020 Jul-Aug;31(4):796-804. DOI: https://doi.org/10.4103/1319-2442.292313 PMid:32801240

15. Tiffin-Richards FE, Costa AS, Holschbach B, Frank RD, Vassiliadou A, Krüger T, et al. The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLoS One. 2014 Oct 27;9(10):e106700. DOI: https://doi.org/10.1371/journal.pone.0106700 PMid:25347578 PMCid:PMC4209968

16. Sprick JD, Nocera JR, Hajjar I, O'Neill WC, Bailey J, Park J. Cerebral blood flow regulation in end-stage kidney disease. Am J Physiol Renal Physiol. 2020;319(5):F782-F791. DOI: https://doi.org/10.1152/ajprenal.00438.2020 PMid:32985235 PMCid:PMC7789989

17. Xie Z, Tong S, Chu X, Feng T, Geng M. Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis. Kidney Dis (Basel). 2022;8(4):275-285. DOI: https://doi.org/10.1159/000524475 PMid:36157262 PMCid:PMC9386403

18. Levassort H, Boucquemont J, Alencar de Pinho N, Lambert O, Helmer C, Metzger M, et al. A new approach for cognitive impairment pattern in chronic kidney disease. Nephrol Dial Transplant. 2024 Apr 26;39(5):848-859. DOI: https://doi.org/10.1093/ndt/gfad244 PMid:37950574 PMCid:PMC11181866

19. Tang X, Han YP, Chai YH, Gong HJ, Xu H, Patel I, et al. Association of kidney function and brain health: A systematic review and meta-analysis of cohort studies. Ageing Res Rev. 2022 Dec;82:101762. DOI: https://doi.org/10.1016/j.arr.2022.101762 PMid:36374833